Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Clinical significance of p53 mutations in adenocarcinoma of the esophagus and cardia.

Ireland AP, Shibata DK, Chandrasoma P, Lord RV, Peters JH, DeMeester TR.

Ann Surg. 2000 Feb;231(2):179-87.

2.

Loss of heterozygosity and immunohistochemistry of adenocarcinomas of the esophagus and gastric cardia.

Marsman WA, Birjmohun RS, van Rees BP, Caspers E, Johan G, Offerhaus A, Bosma PJ, Jan J, van Lanschot B.

Clin Cancer Res. 2004 Dec 15;10(24):8479-85.

3.

p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.

Bian YS, Osterheld MC, Bosman FT, Benhattar J, Fontolliet C.

Mod Pathol. 2001 May;14(5):397-403.

4.

Detection of Barrett's adenocarcinoma of the gastric cardia with sucrase isomaltase and p53.

Iannettoni MD, Lee SS, Bonnell MR, Sell TL, Whyte RI, Orringer MB, Beer DG.

Ann Thorac Surg. 1996 Nov;62(5):1460-5; discussion 1465-6.

PMID:
8893584
5.
6.

P53 mutational status improves estimation of prognosis in patients with curatively resected adenocarcinoma in Barrett's esophagus.

Schneider PM, Stoeltzing O, Roth JA, Hoelscher AH, Wegerer S, Mizumoto S, Becker K, Dittler HJ, Fink U, Siewert JR.

Clin Cancer Res. 2000 Aug;6(8):3153-8.

7.

p53 abnormalities in adenocarcinoma of the gastric cardia and antrum.

Fléjou JF, Gratio V, Muzeau F, Hamelin R.

Mol Pathol. 1999 Oct;52(5):263-8.

8.

Mutations of p53 in Barrett's esophagus and Barrett's cancer: a prospective study of ninety-eight cases.

Schneider PM, Casson AG, Levin B, Garewal HS, Hoelscher AH, Becker K, Dittler HJ, Cleary KR, Troster M, Siewert JR, Roth JA.

J Thorac Cardiovasc Surg. 1996 Feb;111(2):323-31; discussion 331-3.

9.

Comparison of p53 and DNA content abnormalities in adenocarcinoma of the oesophagus and gastric cardia.

Gleeson CM, Sloan JM, McManus DT, Maxwell P, Arthur K, McGuigan JA, Ritchie AJ, Russell SE.

Br J Cancer. 1998;77(2):277-86.

10.

High frequency of Ki-ras amplification and p53 gene mutations in adenocarcinomas of the human esophagus.

Galiana C, Lozano JC, Bancel B, Nakazawa H, Yamasaki H.

Mol Carcinog. 1995 Dec;14(4):286-93.

PMID:
8519418
11.

[Mutation of p53 gene in human cancers of the esophagus and gastric cardia].

Li HC, Lu SX.

Zhonghua Zhong Liu Za Zhi. 1994 May;16(3):172-6. Chinese.

PMID:
7956692
12.

Clinical implications of p53 tumor suppressor gene mutation and protein expression in esophageal adenocarcinomas: results of a ten-year prospective study.

Casson AG, Evans SC, Gillis A, Porter GA, Veugelers P, Darnton SJ, Guernsey DL, Hainaut P.

J Thorac Cardiovasc Surg. 2003 May;125(5):1121-31.

13.

Overexpression of the p53 tumor suppressor gene product in esophageal and gastric carcinomas.

Fléjou JF, Muzeau F, Potet F, Lepelletier F, Fékété F, Hénin D.

Pathol Res Pract. 1994 Dec;190(12):1141-8.

PMID:
7540752
14.

p53 Mutations in carcinoma of the esophagus and gastroesophageal junction.

Sengpiel C, König IR, Rades D, Noack F, Duchrow M, Schild SE, Ludwig D, Homann N.

Cancer Invest. 2009 Jan;27(1):96-104. doi: 10.1080/07357900802161047.

PMID:
19160092
15.

Clinical implications of p53 gene mutation in the progression of Barrett's epithelium to invasive esophageal cancer.

Casson AG, Manolopoulos B, Troster M, Kerkvliet N, O'Malley F, Inculet R, Finley R, Roth JA.

Am J Surg. 1994 Jan;167(1):52-7.

PMID:
8311140
16.

p53 mutations in esophageal tumors from high-incidence areas of China.

Liang YY, Estève A, Martel-Planche G, Takahashi S, Lu SH, Montesano R, Hollstein M.

Int J Cancer. 1995 May 29;61(5):611-4.

PMID:
7768632
17.

Relationship between p53 expression and gastric cancers in cardia and antrum.

Azarhoush R, Keshtkar AA, Amiriani T, Kazemi-Nejad V.

Arch Iran Med. 2008 Sep;11(5):502-6.

18.

Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.

Ruggeri BA, Huang L, Berger D, Chang H, Klein-Szanto AJ, Goodrow T, Wood M, Obara T, Heath CW, Lynch H.

Cancer. 1997 Feb 15;79(4):700-16.

PMID:
9024708
19.

Association of p53 gene mutations with short survival in pancreatic adenocarcinoma.

Nakamori S, Yashima K, Murakami Y, Ishikawa O, Ohigashi H, Imaoka S, Yaegashi S, Konishi Y, Sekiya T.

Jpn J Cancer Res. 1995 Feb;86(2):174-81.

PMID:
7730141
20.

mdm-2 expression correlates with wild-type p53 status in esophageal adenocarcinoma.

Soslow RA, Altorki NK, Yang G, Xie D, Yang CS.

Mod Pathol. 1999 Jun;12(6):580-6.

PMID:
10392633
Items per page

Supplemental Content

Write to the Help Desk